Tonix Pharmaceuticals Holding (TNXP) Assets (2010 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Assets of $257.9 million for Q1 2026, up 33.72% year-over-year from $192.9 million in Q1 2025, and down 6.95% quarter-over-quarter from $277.2 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Assets (2010 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Assets history runs 17 years deep, the most recent figure standing at $257.9 million for Q1 2026.
- In Q1 2026, Assets rose 33.72% year-over-year to $257.9 million; the TTM figure through Mar 2026 stood at $257.9 million (up 33.72% YoY), while the FY2025 annual figure was $277.2 million, up 70.16% from the prior year.
- Assets for Q1 2026 stood at $257.9 million, down from $277.2 million in the prior quarter.
- The five-year high for Assets was $277.2 million in Q4 2025, with the low at $70.3 million in Q2 2024.
- The 5-year median for Assets is $187.4 million (2025), against an average of $190.1 million.
- The sharpest annual moves came in 2024 and 2025: Assets plunged 55.99% in 2024, then jumped 166.49% in 2025.
- Tonix Pharmaceuticals Holding's Assets stood at $225.7 million in 2022, then plunged by 31.56% to $154.5 million in 2023, then gained by 5.46% to $162.9 million in 2024, then soared by 70.16% to $277.2 million in 2025, then retreated by 6.95% to $257.9 million in 2026.
- Business Quant data shows TNXP's Assets at $257.9 million in Q1 2026, $277.2 million in Q4 2025, and $252.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | 254.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 254.09 Mn |
| Mar 31, 2026 | 257.91 Mn |
| Dec 31, 2025 | 277.17 Mn |
| Sep 30, 2025 | 252.44 Mn |
| Jun 30, 2025 | 187.36 Mn |
| Mar 31, 2025 | 192.87 Mn |
| Dec 31, 2024 | 162.89 Mn |
| Sep 30, 2024 | 94.99 Mn |
| Jun 30, 2024 | 70.31 Mn |
| Mar 31, 2024 | 135.34 Mn |
| Dec 31, 2023 | 154.46 Mn |
| Sep 30, 2023 | 139.28 Mn |
| Jun 30, 2023 | 159.74 Mn |
| Mar 31, 2023 | 179.09 Mn |
| Dec 31, 2022 | 225.69 Mn |
| Sep 30, 2022 | 242.65 Mn |
| Jun 30, 2022 | 276.17 Mn |
| Mar 31, 2022 | 223.72 Mn |
| Dec 31, 2021 | 240.90 Mn |
| Sep 30, 2021 | 214.77 Mn |